Intravenous guanethidine in patients with reflex sympathetic dystrophy

被引:19
|
作者
Kaplan, R
Claudio, M
Kepes, E
Gu, XF
机构
[1] Department of Anesthesiology, Albert Einstein College of Medicine
[2] Pain Management Program, Montefiore Medical Center
[3] Statistical Department, New York, NY
[4] Division of Pain Management, Department of Anesthesiology, Montefiore Medical Center, New York, NY
[5] Division of Pain Management, Department of Anesthesiology, Montefiore Medical Center, Bronx, NY 10467
关键词
analgesia; Bier block; guanethidine; pain; sympathectomy; sympathetic dystrophy;
D O I
10.1111/j.1399-6576.1996.tb05553.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Intravenous regional guanethidine Bier block (IVRGBB) has been used predominantly in Europe for treating reflex sympathetic dystrophy (RSD). Our experience in the United States, where its use has been limited, is reported. Methods: Fifty-five patients received IVRGBB for RSD. Upper extremities received 20 mg (10 mg/ml) of guanethidine in 30-50 ml of 0.5% lidocaine; lower extremities received 40 mg in 40-75 ml of lidocaine (volume adjusted for size, weight, or prior adverse effect). Pain severity (mild, moderate, severe, excruciating) was obtained pretreatment. Pain severity and a global clinical assessment (GCA) (resolved, improved, no change, worse) were obtained following each treatment. The final GCA was analyzed vs: pretreatment score; age; sex; pain duration; number of treatments; and precipitating event. Adverse effects were documented. Results: Of 55 enrolled patients, 2 were lost to follow-up, and 2 returned 1 and 4 years later for repeat treatment. Therefore, 53 patients were evaluated for 55 treatments. Age: 38.2 +/- 14.8 (SD) (range 10-77) years. Sex: 11 males, 44 females. Average pain duration: 2.0 +/- 1.7 years (3 days - 7 years). Final assessment occurred at 3.88 +/- 5.21 months (6 days - 22/3 years). Effect on pain resolution-9.1%; improved-14.5%; no change-61.8%; worsening-14.5%. No significant relationship was found between GCA and the factors evaluated. There was a significant positive linear association between pretreatment pain and post treatment GCA (P=0.032). Fifty-six adverse effects occurred in 19 (34.5%) patients (nausea, vomiting, orthostatic hypotension, dizziness, diarrhea, weakness). Conclusions: IVRGBB does not provide long-term pain relief and is associated with adverse effects in over 1/3 of patients. (C) Acta Anaesthesiologica Scandinavica 40 (1996)
引用
收藏
页码:1216 / 1222
页数:7
相关论文
共 50 条
  • [1] TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY BY REGIONAL BLOCK WITH INTRAVENOUS GUANETHIDINE
    BRUXELLE, J
    MENKES, CJ
    [J]. REVUE DU RHUMATISME, 1982, 49 (12): : 867 - 869
  • [2] GUANETHIDINE FOR REFLEX SYMPATHETIC DYSTROPHY
    YASUDA, JM
    SCHROEDER, DJ
    [J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (03) : 338 - 341
  • [3] CLINICAL EFFECTS OF REGIONAL INTRAVENOUS GUANETHIDINE (ISMELIN) IN REFLEX SYMPATHETIC DYSTROPHY
    DRIESSEN, JJ
    VANDERWERKEN, C
    NICOLAI, JPA
    CRUL, JF
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1983, 27 (06) : 505 - 509
  • [4] REFLEX SYMPATHETIC DYSTROPHY (CAUSALGIA) TREATMENT WITH GUANETHIDINE
    TABIRA, T
    SHIBASAKI, H
    KUROIWA, Y
    [J]. ARCHIVES OF NEUROLOGY, 1983, 40 (07) : 430 - 432
  • [5] TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY BY REGIONAL SYMPATHETIC BLOCKADE WITH GUANETHIDINE
    JEANDEL, P
    PRIGENT, D
    GILETTE, B
    IMBERT, P
    ANGEL, G
    AUBERT, M
    [J]. ANNALES DE MEDECINE INTERNE, 1989, 140 (03): : 166 - 168
  • [6] REGIONAL SYMPATHETIC GUANETHIDINE BLOCKS FOR THE TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY OF THE LIMBS
    EULRY, F
    LECHEVALIER, D
    BON, E
    CROZES, P
    CLAUDEPIERRE, P
    ALLIAUME, C
    PATS, B
    PATTIN, S
    [J]. SEMAINE DES HOPITAUX, 1991, 67 (30-31): : 1365 - 1371
  • [7] Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy - Intravenous regional guanethidine blockade is a safe and effective treatment
    Lamacraft, G
    Price, CM
    Prosser, ASJ
    Rogers, PD
    Pounder, D
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7160): : 752 - 752
  • [8] INTRAVENOUS REGIONAL GUANETHIDINE IN THE TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY CAUSALGIA - A RANDOMIZED, DOUBLE-BLIND-STUDY
    RAMAMURTHY, S
    HOFFMAN, J
    ABADIR, A
    BAYSINGER, C
    EDWARDS, BE
    EDWARDS, WT
    HARE, BD
    INGALL, JR
    MANGIERI, EA
    MOGELNICKI, SR
    RACZ, GA
    RAJ, P
    RAUCK, RL
    ROSENBLUM, S
    STRICKLAND, J
    YALAMANCHILI, P
    [J]. ANESTHESIA AND ANALGESIA, 1995, 81 (04): : 718 - 723
  • [9] Does peri-operative guanethidine prevent reflex sympathetic dystrophy?
    Gschwind, C
    Fricker, R
    Lacher, G
    Jung, M
    [J]. JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1995, 20B (06): : 773 - 775
  • [10] INTRAVENOUS RESERPINE FOR TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY
    CHUINARD, RG
    DABEZIES, EJ
    GOULD, JS
    MURPHY, GA
    MATTHEWS, RE
    [J]. SOUTHERN MEDICAL JOURNAL, 1981, 74 (12) : 1481 - 1484